Immunogenicity in Macaques of the Clinical Product for a Clade B DNAMVA HIV Vaccine Elicitation of IFN-γ, IL-2, and TNF-α Coproducing CD4 and CD8 T Cells.

The clinical product for a clade B HIV DNAMVA vaccine expressing Gag, Pol, and Env has been tested for immunogenicity in macaques. Responding T cells were at the threshold for detection following DNA priming at weeks 0 and 8 but underwent sharp expansions and contractions following MVA boosting at weeks 16 and 24. Both CD4 and CD8 T cell responses had high frequencies of cytokine coproducing cells with >50 of the memory cells coproducing multiple cytokines including IL-2. The highest responses were elicited to Gag, followed by Env and then Pol. In two of six macaques, the vaccine also elicited low levels of neutralizing Ab for easy to neutralize clade B isolates. [ABSTRACT FROM AUTHOR]